Next-Gen Sequencing Could Unlock Ebola’s Secrets
The Ebola outbreak in West Africa has dominated recent newscasts and shocked…
Drug Development Gets Even More Personal, Precise and Tailored
As we’ve discussed, Eric Topol’s “How to Change Medicine” provides valuable insights on…
Roche’s Proposed Takeover of Illumina—Game On for Universal DNA Sequencing?
There appears to be a full-scale race underway to bring affordable next-gen…
Through the Murky Slog: Part II—A New Light for Cancer Therapies?
Last week, we discussed new drug approvals that reflected a paradigm shift…
Seeking Holy Grail: Quest for Stem Cells from Embryos Continues
In a recent paper that spawned news articles and blogs worldwide, researchers announced the generation…
Treating Cancer – Moving Beyond the Whack-a-Mole Approach
In his latest Wall Street Journal column (“Drugs That Are as Smart…
Companion Diagnostics: More Targeted Medicine on the Horizon
It’s increasingly clear to anyone who deals with human health – from…
#Bio2011: After the Party is Over
For the thousands of life science industry representatives who attend the Biotechnology Industry…
